Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
Abstract It is well acknowledged that allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for numerous malignant blood diseases, which has also been applied to autoimmune diseases for more than a decade. Whereas graft-versus-host disease (GVHD) occurs after allog...
Main Authors: | Xinyi Zhou, Nan Jin, Fei Wang, Baoan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-020-01193-z |
Similar Items
-
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
by: Nancy Y. Villa, et al.
Published: (2016-03-01) -
Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01) -
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation
by: Giuseppe Tarantino, et al.
Published: (2021-09-01) -
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
by: Kilian Kelly, et al.
Published: (2021-10-01) -
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
by: Mehrdad Hefazi, et al.
Published: (2021-09-01)